These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 31434953)

  • 41. Tumor Growth Analysis of Ewing Sarcoma Cell Lines Using Subcutaneous Xenografts in Mice.
    Cidre-Aranaz F; Ohmura S
    Methods Mol Biol; 2021; 2226():191-199. PubMed ID: 33326103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.
    Schuetze SM
    J Natl Compr Canc Netw; 2007 Apr; 5(4):449-55. PubMed ID: 17442235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.
    Ambati SR; Shieh JH; Pera B; Lopes EC; Chaudhry A; Wong EW; Saxena A; Su TL; Moore MA
    Oncotarget; 2016 Jul; 7(28):43062-43075. PubMed ID: 27248664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma?
    Burns JS; Abdallah BM; Schrøder HD; Kassem M
    Histol Histopathol; 2008 Oct; 23(10):1229-40. PubMed ID: 18712675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
    Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
    Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations.
    Loh AHP; Stewart E; Bradley CL; Chen X; Daryani V; Stewart CF; Calabrese C; Funk A; Miller G; Karlstrom A; Krafcik F; Goshorn DR; Vogel P; Bahrami A; Shelat A; Dyer MA
    Cancer Lett; 2019 Feb; 442():262-270. PubMed ID: 30395907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
    Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
    J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro chemosensitivity assay for human osteosarcoma using tumor xenografts.
    Fujisaki T; Wada T; Takahashi M; Yamawaki S; Ishii S
    Clin Orthop Relat Res; 1995 Apr; (313):279-85. PubMed ID: 7641491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients.
    Winderen M; Stenwig AE; Solheim OP; Saeter G; Aas M
    Acta Orthop Scand Suppl; 1999 Jun; 285():11-7. PubMed ID: 10429616
    [No Abstract]   [Full Text] [Related]  

  • 50. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone.
    Oyama R; Takahashi M; Kito F; Sakumoto M; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Jun; 54(6):458-467. PubMed ID: 29845452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.
    Okano M; Oshi M; Butash A; Okano I; Saito K; Kawaguchi T; Nagahashi M; Kono K; Ohtake T; Takabe K
    J Mammary Gland Biol Neoplasia; 2020 Mar; 25(1):27-36. PubMed ID: 32109311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.
    Bandyopadhyay A; Favours E; Phelps DA; Pozo VD; Ghilu S; Kurmashev D; Michalek J; Trevino A; Guttridge D; London C; Hirotani K; Zhang L; Kurmasheva RT; Houghton PJ
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29080385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and tumor response in osteosarcoma and Ewing's sarcoma.
    Böhling T; Bacchini P; Bertoni F; Bjerkehagen B; Domanski H; Kindblom LG; Meis-Kindblom J; Wejde J
    Acta Orthop Scand Suppl; 2004 Apr; 75(311):72-6. PubMed ID: 15188668
    [No Abstract]   [Full Text] [Related]  

  • 54. Advances in the Treatment of Pediatric Bone Sarcomas.
    Grohar PJ; Janeway KA; Mase LD; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2017; 37():725-735. PubMed ID: 28561686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas.
    Asano N; Takeshima H; Yamashita S; Takamatsu H; Hattori N; Kubo T; Yoshida A; Kobayashi E; Nakayama R; Matsumoto M; Nakamura M; Ichikawa H; Kawai A; Kondo T; Ushijima T
    Sci Rep; 2019 Dec; 9(1):20360. PubMed ID: 31889115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.
    Sampson VB; Kamara DF; Kolb EA
    Expert Opin Drug Discov; 2013 Oct; 8(10):1181-9. PubMed ID: 23844615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model].
    Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
    Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
    Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas.
    Pascual-Pasto G; Castillo-Ecija H; Unceta N; Aschero R; Resa-Pares C; Gómez-Caballero A; Vila-Ubach M; Muñoz-Aznar O; Suñol M; Burgueño V; Gomez-Gonzalez S; Sosnik A; Ibarra M; Schaiquevich P; de Álava E; Tirado OM; Mora J; Carcaboso AM
    J Control Release; 2022 Feb; 342():81-92. PubMed ID: 34974029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting.
    Kailayangiri S; Altvater B; Meltzer J; Pscherer S; Luecke A; Dierkes C; Titze U; Leuchte K; Landmeier S; Hotfilder M; Dirksen U; Hardes J; Gosheger G; Juergens H; Rossig C
    Br J Cancer; 2012 Mar; 106(6):1123-33. PubMed ID: 22374462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.